ロード中...
Getting to the point in point-of-care diagnostics for tuberculosis
Tuberculosis (TB) continues to affect over 10 million people per year worldwide. Despite advances in diagnosis, smear microscopy insufficiently detects pulmonary disease, with test result reporting taking longer than a day. While urine assays to detect the lipopolysaccharide lipoarabinomannan (LAM),...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7598045/ https://ncbi.nlm.nih.gov/pubmed/32986020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI142497 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|